D. Meyer

Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study

P. Buck, C. Herrman, E. Fox, 2010, Journal of Neurology.

Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis.

A. Coles, D. Margolin, P. Oyuela, 2013, Multiple sclerosis and related disorders.

Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report.

M. Rocco, P. Persad, A. Farland, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative study

P. Buck, C. Herrman, E. Fox, 2010, Journal of Neurology.